Literature DB >> 30167931

The structure of monoamine oxidases: past, present, and future.

Luca Giacinto Iacovino1, Francesca Magnani1, Claudia Binda2.   

Abstract

The first crystal structure of mammalian monoamine oxidases (MAOs) was solved in 2002; almost 65 years after, these FAD-dependent enzymes were discovered and classified as responsible for the oxidation of aromatic neurotransmitters. Both MAO A and MAO B feature a two-domain topology characterized by the Rossmann fold, interacting with dinucleotide cofactors, which is intimately associated to a substrate-binding domain. This globular body is endowed with a C-terminal α-helix that anchors the protein to the outer mitochondrial phospholipid bilayer. As monotopic membrane proteins, the structural elucidation of MAOs was a challenging task that required the screening of different detergent conditions for their purification and crystallization. MAO A and MAO B structures differ both in their oligomerization architecture and in details of their active sites. Purified human MAO B and rat MAO A are dimeric, whereas human MAO A was found to be monomeric, which is believed to result from the detergent treatments used to extract the protein from the membrane. The active site of MAOs consists of a hydrophobic cavity located in front of the flavin cofactor and extending to the protein surface. Some structural features are highly conserved in the two isozymes, such as a Tyr-Tyr aromatic sandwich in front of the flavin ring and a Lys residue hydrogen-bonded to the cofactor N5 atom, whereas a pair of gating residues (Phe208/Ile335 in MAO A; Ile199/Tyr326 in MAO B) specifically determines the different substrate and inhibitor properties of the two enzymes.

Entities:  

Keywords:  Amine oxidase; Drug design; Enzyme active site; Flavin; Inhibitor; Membrane protein; Mitochondrial membrane

Mesh:

Substances:

Year:  2018        PMID: 30167931     DOI: 10.1007/s00702-018-1915-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  42 in total

1.  High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae.

Authors:  Min Li; Frantisĕk Hubálek; Paige Newton-Vinson; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2002-02       Impact factor: 1.650

2.  Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane?

Authors:  A I de Kroon; D Dolis; A Mayer; R Lill; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1997-04-03

Review 3.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

4.  Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

Authors:  Daniele Bonivento; Erika M Milczek; G Reid McDonald; Claudia Binda; Andrew Holt; Dale E Edmondson; Andrea Mattevi
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

5.  The 'gating' residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition.

Authors:  Erika M Milczek; Claudia Binda; Stefano Rovida; Andrea Mattevi; Dale E Edmondson
Journal:  FEBS J       Date:  2011-11-03       Impact factor: 5.542

Review 6.  Pichia pastoris as an expression host for membrane protein structural biology.

Authors:  Bernadette Byrne
Journal:  Curr Opin Struct Biol       Date:  2015-02-03       Impact factor: 6.809

Review 7.  The new generation of monoamine oxidase inhibitors.

Authors:  A M Cesura; A Pletscher
Journal:  Prog Drug Res       Date:  1992

Review 8.  Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease.

Authors:  Moussa B H Youdim; Lana Kupershmidt; Tamar Amit; Orly Weinreb
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

9.  Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis.

Authors:  Joana Reis; Nicola Manzella; Fernando Cagide; Jeanne Mialet-Perez; Eugenio Uriarte; Angelo Parini; Fernanda Borges; Claudia Binda
Journal:  J Med Chem       Date:  2018-04-20       Impact factor: 7.446

10.  Presenting your structures: the CCP4mg molecular-graphics software.

Authors:  S McNicholas; E Potterton; K S Wilson; M E M Noble
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  4 in total

1.  The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells.

Authors:  Najla O Zarmouh; Samia S Messeha; Nelly Mateeva; Madhavi Gangapuram; Kacy Flowers; Suresh V K Eyunni; Wang Zhang; Kinfe K Redda; Karam F A Soliman
Journal:  Molecules       Date:  2020-05-11       Impact factor: 4.411

Review 2.  Amphetamine Derivatives as Monoamine Oxidase Inhibitors.

Authors:  Miguel Reyes-Parada; Patricio Iturriaga-Vasquez; Bruce K Cassels
Journal:  Front Pharmacol       Date:  2020-01-23       Impact factor: 5.810

3.  Rational Redesign of Monoamine Oxidase A into a Dehydrogenase to Probe ROS in Cardiac Aging.

Authors:  Luca Giacinto Iacovino; Nicola Manzella; Jessica Resta; Maria Antonietta Vanoni; Laura Rotilio; Leonardo Pisani; Dale Edward Edmondson; Angelo Parini; Andrea Mattevi; Jeanne Mialet-Perez; Claudia Binda
Journal:  ACS Chem Biol       Date:  2020-06-30       Impact factor: 5.100

4.  Design, Synthesis, Docking Studies and Monoamine Oxidase Inhibition of a Small Library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles.

Authors:  Paolo Guglielmi; Simone Carradori; Giulio Poli; Daniela Secci; Roberto Cirilli; Giulia Rotondi; Paola Chimenti; Anél Petzer; Jacobus P Petzer
Journal:  Molecules       Date:  2019-01-29       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.